HOME >> MEDICINE >> NEWS
Enhanced external counterpulsation reduces angina, says University of Pittsburgh study

PITTSBURGH, Feb. 27 Patients with angina (chest pain) and left ventricular dysfunction respond very well to treatment using enhanced external counterpulsation (EECP), with little or no future heart failure events, according to researchers from the Cardiovascular Institute at the University of Pittsburgh Medical Center (UPMC). The researchers suggest that EECP is an effective therapy for the 2.4 million Americans with coronary artery disease who are not candidates for invasive revascularization procedures, such as balloon angioplasty, heart bypass or stent implantation. Their findings were reported in the January issue of the American Journal of Cardiology.

EECP is a non-invasive circulatory procedure whereby long inflatable cuffs are wrapped around a patient's calves, thighs and buttocks. While the patient lies on a table, the cuffs are sequentially inflated while the heart is at rest (diastole), and then simultaneously deflated just before the heart begins to pump (systole). The heart rhythms are picked up through a computerized EKG machine. The benefits of EECP include increased blood flow to the heart and coronary arteries, thereby enabling the heart to perform at an optimal level.

Using data from the International EECP Patient Registry, the study included 363 patients age 67 and older with chest pain accompanied by severe left ventricular dysfunction. Patients underwent 32 one-hour EECP sessions five days a week for seven weeks. Prior to the study most of the patients reported that their quality of life was poor. Among the patients in the study, 85 percent previously had a heart attack, 72 percent had coronary bypass and 70 percent had some other type of invasive heart procedure. All patients were assessed at six months, one year and two years. By the end of the study, the patients reported significantly less chest pain and an improvement in quality of life. The overall two year survival rate was 83 percent and event-free survival rate was 70 p
'"/>


27-Feb-2006


Page: 1 2

Related medicine news :

1. Enhanced depression care may be cost-effective for employers
2. Enhanced brain response to smoking cues found in African American compared with caucasian smokers
3. Enhanced imaging techniques could improve medical diagnosis
4. FDA safety alerts for automated external defibrillators occur frequently
5. Automated external defibrillators are frequently recalled
6. New data finds recalls of automated external defibrillators to be common
7. CPR and external defibrillator training may decrease adolescent sports-related deaths
8. Nonhormonal drug reduces hot flashes in men treated for prostate cancer
9. Circumcision reduces HIV infection risk
10. Retinol lotion reduces the fine wrinkles from natural aging of skin
11. Improving communication with families of dying patients reduces stress, anxiety and depression

Post Your Comments:
(Date:3/4/2015)... (PRWEB) March 04, 2015 According to ... millions of people in the U.S. suffer from gastroesophageal ... Medications are commonly prescribed to control acid production, but ... procedures can overly correct the problem and lead to ... Opportunity, GERD occurs when the lower esophageal sphincter does ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 The Conrad ... a total of $6.9 million, which will help ... Niger and Burkina Faso. , The programs cover three ... first will focus on fixing water points in disrepair, ... of local people to maintain water points and ensuring ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 A new ... showing promise in terms of extending life. Studies ... that this new dieting routine can help extend life ... production clearly has long term benefits, many suffering from ... a quicker substitute is necessary. As an alternative to ...
(Date:3/4/2015)... Jose, California (PRWEB) March 04, 2015 ... as chemical preparations for enhancing the appearance of the ... using a wide variety of therapeutic agents to achieve ... lifestyle products in a society obsessed with physical beauty, ... reliant on the production and sales of cosmetics. Growth ...
(Date:3/4/2015)... The defibrillators report provides insights into the growth ... the global market is expected to grow at a ... by 2019. It expects the emerging markets to provide ... established players in the market. , According to the ... at the highest CAGR during the next five years. ...
Breaking Medicine News(10 mins):Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 2Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 4Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 2Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 3Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 2Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 3
(Date:3/4/2015)... 2015 TeraRecon, ( www.terarecon.com ), ... Unternehmen, baut seine Präsenz im EMEA-Markt mit ... of Sales und Stefan Phillips ... Logo - http://photos.prnewswire.com/prnh/20150303/179359LOGO ... den Verkauf und die Geschäftsentwicklung in Europa ...
(Date:3/4/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... 27 th Annual ROTH Conference, taking place March ...  Dr. Michael Berelowitz , Chairman of the ... overview on March 10, 2015.   ...
(Date:3/4/2015)... Company plc (NYSE: PRGO ; TASE) today announced ... will present at the 2015 Barclays Global Healthcare Conference ... Loews Miami Beach Hotel in Miami, FL. ... http://perrigo.investorroom.com/events-webcasts . From its beginnings as a packager ... in Ireland , has grown to become ...
Breaking Medicine Technology:TeraRecon baut seine Präsenz in EMEA aus 2TeraRecon baut seine Präsenz in EMEA aus 3Oramed to Present at the ROTH Conference 2Oramed to Present at the ROTH Conference 3Perrigo Company To Present At The 2015 Barclays Global Healthcare Conference 2
Cached News: